NASDAQ:SABS | EBITDA Margin | SAB Biotherapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2020-12-31 to 2024-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2024-12-31-8060.15%
2024-06-30-3496.92%
2024-03-31-998.08%
2023-12-31-5885.45%
2023-09-30-341.10%
2023-06-30-6520.99%
2023-03-31-1119.18%
2022-12-31-322.15%
2022-09-30-192.70%
2022-06-30-91.22%
2022-03-31-51.44%
2021-12-31-60.81%
2021-09-30-24.67%
2021-06-30-14.35%
2021-03-316.20%

Annual EBITDA Margin

DateEBITDA Margin
2024-12-31-2889.02%
2023-12-31-1537.40%
2022-12-31-107.71%
2021-12-31-19.56%
2020-12-3137.91%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.